Teladoc Health, Inc.
General ticker "TDOC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $1.5B (TTM average)
Teladoc Health, Inc. follows the US Stock Market performance with the rate: 10.4%.
Estimated limits based on current volatility of 2.9%: low 5.02$, high 5.32$
Factors to consider:
- Total employees count: 5500 (-1.8%) as of 2024
- US accounted for 84.1% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Net losses and accumulated deficit, Customer relationships, Cybersecurity threats, Regulatory and compliance, Strategic risks and growth management
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.32$, 11.88$]
- 2026-12-31 to 2027-12-31 estimated range: [5.14$, 11.60$]
Financial Metrics affecting the TDOC estimates:
- Negative: with PPE of -9.8 at the end of fiscal year the price was high
- Negative: negative Operating income
- Positive: Operating cash flow per share per price, % of 23.40 > 12.96
- Positive: Inventory ratio change, % of 0.63 <= 0.80
- Positive: Interest expense per share per price, % of 1.57 <= 3.28
- Positive: 42.68 < Shareholder equity ratio, % of 48.48 <= 64.29
- Negative: negative Net income
Short-term TDOC quotes
Long-term TDOC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2,602.41MM | $2,569.57MM | $2,529.98MM |
| Operating Expenses | $2,850.97MM | $3,590.46MM | $2,792.93MM |
| Operating Income | $-248.55MM | $-1,020.89MM | $-262.95MM |
| Non-Operating Income | $28.95MM | $27.23MM | $27.43MM |
| Interest Expense | $22.28MM | $23.80MM | $19.71MM |
| R&D Expense | $348.52MM | $307.27MM | $277.92MM |
| Income(Loss) | $-219.61MM | $-993.65MM | $-235.53MM |
| Taxes | $0.76MM | $7.59MM | $-35.21MM |
| Profit(Loss)* | $-220.37MM | $-1,001.25MM | $-200.32MM |
| Stockholders Equity | $2,326.07MM | $1,491.08MM | $1,385.71MM |
| Inventory | $29.51MM | $38.14MM | $38.20MM |
| Assets | $4,392.37MM | $3,516.52MM | $2,858.30MM |
| Operating Cash Flow | $350.02MM | $293.68MM | $294.36MM |
| Capital expenditure | $156.35MM | $10.79MM | $8.89MM |
| Investing Cash Flow | $-156.35MM | $-124.05MM | $-266.00MM |
| Financing Cash Flow | $10.85MM | $8.31MM | $-551.65MM |
| Earnings Per Share** | $-1.36 | $-5.87 | $-1.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.